Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1

Clinical trial NCT07070999 · RECRUITING

Trial details

NCT number: NCT07070999
Sponsor: Gemma Biotherapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Spinal Muscular Atrophy Type I

Start date: 2026-01-06
Primary completion: 2028-12-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.